{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T21:00:54Z","timestamp":1780174854556,"version":"3.54.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Secretariat of Science Humanities Technology and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005739","name":"Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","award":["IT-201524"],"award-info":[{"award-number":["IT-201524"]}],"id":[{"id":"10.13039\/501100005739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006087","name":"National Autonomous University of Mexico Directorate General of Academic Staff Affairs","doi-asserted-by":"publisher","award":["IT-202824"],"award-info":[{"award-number":["IT-202824"]}],"id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biotechnology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jbiotec.2026.04.009","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T14:50:24Z","timestamp":1776523824000},"page":"26-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparative analysis of manufacturability and binding of various bispecific antibody architectures"],"prefix":"10.1016","volume":"416","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0028-4588","authenticated-orcid":false,"given":"Juan Carlos","family":"Rivera-Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9005-3496","authenticated-orcid":false,"given":"Octavio T.","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Palomares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbiotec.2026.04.009_bib1","first-page":"1","article-title":"A brain-shuttled antibody targeting alpha synuclein aggregates for the treatment of synucleinopathies","volume":"11","author":"An","year":"2025","journal-title":"Npj Park. S Dis."},{"key":"10.1016\/j.jbiotec.2026.04.009_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nature18938","article-title":"Structural basis of potent Zika\u2013dengue virus antibody cross-neutralization","volume":"536","author":"Barba-Spaeth","year":"2016","journal-title":"Nat"},{"issue":"5","key":"10.1016\/j.jbiotec.2026.04.009_bib3","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/btpr.1767","article-title":"Free Light Chain Content in Culture Media Reflects Recombinant Monoclonal Antibody Productivity and Quality","volume":"29","author":"Bhoskar","year":"2013","journal-title":"Biotechnol. Prog."},{"issue":"4","key":"10.1016\/j.jbiotec.2026.04.009_bib4","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/bit.22135","article-title":"Engineering and Expression of a Chimeric Transferrin Receptor Monoclonal Antibody for Blood\u2013Brain Barrier Delivery in the Mouse","volume":"102","author":"Boado","year":"2008","journal-title":"Biotechnol. Bioeng."},{"issue":"2","key":"10.1016\/j.jbiotec.2026.04.009_bib5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.abb.2012.03.016","article-title":"Development of tetravalent IgG1 dual targeting IGF-1R\u2013EGFR antibodies with potent tumor inhibition","volume":"526","author":"Croasdale","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"issue":"9","key":"10.1016\/j.jbiotec.2026.04.009_bib6","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/bit.28392","article-title":"Mimotope discovery as a tool to design a vaccine against Zika and dengue viruses","volume":"120","author":"Cuevas-Ju\u00e1rez","year":"2023","journal-title":"Biotechnol. Bioeng."},{"issue":"4","key":"10.1016\/j.jbiotec.2026.04.009_bib7","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s12257-023-0057-9","article-title":"Tuning the assembly of bispecific antibodies by playing on differential polypeptide chain molar ratios","volume":"28","author":"De Temmerman","year":"2023","journal-title":"Biotechnol. Bioprocess Eng."},{"key":"10.1016\/j.jbiotec.2026.04.009_bib8","first-page":"145","article-title":"Design and generation of DVD-Ig\u2122 molecules for dual-specific targeting","volume":"899","author":"DiGiammarino","year":"2012"},{"key":"10.1016\/j.jbiotec.2026.04.009_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.omtm.2020.08.014","article-title":"Tetravalent bispecific tandem antibodies improve brain exposure and efficacy in an amyloid transgenic mouse model","volume":"19","author":"Do","year":"2020","journal-title":"Mol. Ther. Meth. Clin. Dev."},{"key":"10.1016\/j.jbiotec.2026.04.009_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ddtec.2020.10.002","article-title":"Recent advancements in DVD-Ig based therapeutic development","volume":"34","author":"Dong","year":"2019","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.jbiotec.2026.04.009_bib11","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s12033-021-00373-0","article-title":"Production of scFv, Fab, and IgG of CR3022 Antibodies Against SARS\u2011CoV\u20112 Using Silkworm\u2011Baculovirus Expression System","volume":"63","author":"Ebihara","year":"2021","journal-title":"Mol. Biotechnol."},{"issue":"5","key":"10.1016\/j.jbiotec.2026.04.009_bib12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.molcel.2009.04.028","article-title":"An unfolded CH1 domain controls the assembly and secretion of IgG antibodies","volume":"34","author":"Feige","year":"2009","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.jbiotec.2026.04.009_bib13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.7150\/thno.17155","article-title":"Bivalent brain shuttle increases antibody uptake by monovalent binding to the transferrin receptor","volume":"7","author":"Hultqvist","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jbiotec.2026.04.009_bib14","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.1073\/pnas.85.16.5879","article-title":"Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli","volume":"85","author":"Huston","year":"1988","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.jbiotec.2026.04.009_bib15","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4161\/mabs.23977","article-title":"Structure reveals function of the dual variable domain immunoglobulin (DVD-IgTM) molecule","volume":"5","author":"Jakob","year":"2013","journal-title":"mAbs"},{"issue":"5","key":"10.1016\/j.jbiotec.2026.04.009_bib16","doi-asserted-by":"crossref","first-page":"646","DOI":"10.4161\/mabs.25632","article-title":"Improving biophysical properties of a bispecific antibody scaffold to aid developability","volume":"5","author":"Kreudenstein","year":"2013","journal-title":"mAbs"},{"issue":"9","key":"10.1016\/j.jbiotec.2026.04.009_bib17","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1074\/jbc.M116.767749","article-title":"Effector-attenuating substitutions that maintain antibody stability and reduce toxicity in mice","volume":"292","author":"Lo","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jbiotec.2026.04.009_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2231129","article-title":"Manufacturability and functionality assessment of different formats of T-cell engaging bispecific antibodies","volume":"15","author":"Loh","year":"2023","journal-title":"mAbs"},{"key":"10.1016\/j.jbiotec.2026.04.009_bib19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbrc.2004.04.060","article-title":"The effect of variable domain orientation and arrangement on the antigen-binding activity of a recombinant human bispecific diabody","volume":"318","author":"Lu","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbiotec.2026.04.009_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-025-01190-2","article-title":"Technological advancements in antibody-based therapeutics for treatment of diseases","volume":"32","author":"Lu","year":"2025","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jbiotec.2026.04.009_bib21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nbt0798-677","article-title":"An efficient route to human bispecific IgG","volume":"16","author":"Merchant","year":"1998","journal-title":"Nat. Biotechnol."},{"issue":"6292","key":"10.1016\/j.jbiotec.2026.04.009_bib22","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1126\/science.aaf0899","article-title":"Real-time quantification of single RNA translation dynamics in living cells","volume":"352","author":"Morisaki","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jbiotec.2026.04.009_bib23","first-page":"18","article-title":"Biology drives the discovery of bispecific antibodies as innovative therapeutics","volume":"3","author":"Nie","year":"2020","journal-title":"Antib. Ther."},{"key":"10.1016\/j.jbiotec.2026.04.009_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuron.2013.10.061","article-title":"Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle","volume":"81","author":"Niewoehner","year":"2014","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.jbiotec.2026.04.009_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/protein\/gzp077","article-title":"A modular IgG-scFv bispecific antibody topology","volume":"23","author":"Orcutt","year":"2009","journal-title":"Protein Eng. Des. Sel."},{"issue":"1","key":"10.1016\/j.jbiotec.2026.04.009_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/biomethods\/bpab007","article-title":"A two-step PCR assembly for construction of gene variants across large mutational distances","volume":"6","author":"Routh","year":"2021","journal-title":"Biol. Method. Protoc."},{"issue":"1","key":"10.1016\/j.jbiotec.2026.04.009_bib27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1021\/bp049780w","article-title":"On the optimal ratio of heavy to light chain genes for efficient recombinant antibody production by CHO cells","volume":"21","author":"Schlatter","year":"2005","journal-title":"Biotechnol. Prog."},{"issue":"10","key":"10.1016\/j.jbiotec.2026.04.009_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/protein\/gzw040","article-title":"Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions","volume":"29","author":"Schlothauer","year":"2016","journal-title":"Protein Eng. Des. Sel."},{"issue":"11","key":"10.1016\/j.jbiotec.2026.04.009_bib29","first-page":"1","article-title":"Grabody B, an IGF1 receptor-based shuttle, mediates efficient delivery of biologics across the blood-brain barrier","volume":"2","author":"Shin","year":"2022","journal-title":"Cell Rep. Method"},{"issue":"105529","key":"10.1016\/j.jbiotec.2026.04.009_bib30","first-page":"1","article-title":"Removal of half antibody, hole-hole homodimer and aggregates during bispecific antibody purification using MMC ImpRes mixed-mode chromatography","volume":"167","author":"Tang","year":"2019","journal-title":"Protein Expr. Purif."},{"issue":"4","key":"10.1016\/j.jbiotec.2026.04.009_bib31","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1080\/07388551.2022.2047004","article-title":"The secretory pathway \u2013 the key function for unlocking the potential of Chinese hamster ovary cell factories for manufacturing therapeutic proteins","volume":"43","author":"Torres","year":"2023","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.jbiotec.2026.04.009_bib32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.celrep.2017.12.019","article-title":"Brain shuttle antibody for Alzheimer\u2019s disease with attenuated peripheral effector function due to an inverted binding mode","volume":"22","author":"Weber","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbiotec.2026.04.009_bib33","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(25)01954-3","article-title":"Izalontamab brengitecan, an EGFR and HER3 bispecific antibody\u2013drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China","volume":"406","author":"Yang","year":"2025","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.jbiotec.2026.04.009_bib34","first-page":"1","article-title":"Structural design of tetravalent T-cell engaging bispecific antibodies: improve developability by engineering disulfide bonds","volume":"15","author":"Yu","year":"2021","journal-title":"J. Biol. Eng."},{"issue":"1","key":"10.1016\/j.jbiotec.2026.04.009_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1759-7714.15178","article-title":"Advances in new targets for immunotherapy of small cell lung cancer","volume":"15","author":"Zheng","year":"2023","journal-title":"Thorac. Cancer"}],"container-title":["Journal of Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165626001318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165626001318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T20:21:26Z","timestamp":1780172486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168165626001318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":35,"alternative-id":["S0168165626001318"],"URL":"https:\/\/doi.org\/10.1016\/j.jbiotec.2026.04.009","relation":{},"ISSN":["0168-1656"],"issn-type":[{"value":"0168-1656","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of manufacturability and binding of various bispecific antibody architectures","name":"articletitle","label":"Article Title"},{"value":"Journal of Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbiotec.2026.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}